Blood cancers, Cell type, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial was comparing rituximab (Mabthera) with 'watch and wait' for people with follicular lymphoma who didn't have symptoms. This trial was supported by Cancer Research UK.
Recruitment start: 4 October 2004
Recruitment end: 1 May 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Kirit Ardeshna
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Lymphoma Association
NIHR Clinical Research Network: Cancer
Roche
This is Cancer Research UK trial number CRUKE/03/016.
Last reviewed: 17 Dec 2010
CRUK internal database number: 385
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
